Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Brandi

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Translational Cancer Research|February 4, 2022
Hot topics in cholangiocarcinomaGiovanni Brandi
Cancer Treatment and Research Communications|March 22, 2021
TRK inhibition in cholangiocarcinoma: Trying to teach an old dog new tricksAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 16, 2021
First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: "And Yet It Moves!"Alessandro Rizzo, Giovanni Brandi
Cells|May 13, 2023
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A ReviewSimona Tavolari, Giovanni Brandi
International Journal of Molecular Sciences|September 23, 2022
IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?Giovanni Brandi, Alessandro Rizzo
International Journal of Molecular Sciences|June 5, 2019
Microbiota: Overview and Implication in Immunotherapy-Based Cancer TreatmentsGiovanni Brandi, Giorgio Frega
Expert Review of Gastroenterology & Hepatology|August 23, 2022
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstructionAlessandro Rizzo, Giovanni Brandi
Journal of Gastrointestinal Oncology|May 17, 2024
The emerging role of intra-tumoral bacteriaGiovanni Brandi, Giorgio Frega
Expert Review of Gastroenterology & Hepatology|February 11, 2021
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancerAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 7, 2021
Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinomaAlessandro Rizzo, Giovanni Brandi
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Translational Cancer Research|February 4, 2022
Hot topics in cholangiocarcinomaGiovanni Brandi
Cancer Treatment and Research Communications|March 22, 2021
TRK inhibition in cholangiocarcinoma: Trying to teach an old dog new tricksAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 16, 2021
First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: "And Yet It Moves!"Alessandro Rizzo, Giovanni Brandi
Cells|May 13, 2023
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A ReviewSimona Tavolari, Giovanni Brandi
International Journal of Molecular Sciences|September 23, 2022
IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?Giovanni Brandi, Alessandro Rizzo
International Journal of Molecular Sciences|June 5, 2019
Microbiota: Overview and Implication in Immunotherapy-Based Cancer TreatmentsGiovanni Brandi, Giorgio Frega
Expert Review of Gastroenterology & Hepatology|August 23, 2022
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstructionAlessandro Rizzo, Giovanni Brandi
Journal of Gastrointestinal Oncology|May 17, 2024
The emerging role of intra-tumoral bacteriaGiovanni Brandi, Giorgio Frega
Expert Review of Gastroenterology & Hepatology|February 11, 2021
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancerAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 7, 2021
Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinomaAlessandro Rizzo, Giovanni Brandi
Pageof 25